Trialbee collaborates with TriNetX.
M2 EQUITYBITES-October 17, 2019-Trialbee collaborates with TriNetX
(C)2019 M2 COMMUNICATIONS http://www.m2.com
Trialbee, a technology provider in patient matching and engagement, is collaborating with TriNetX, a global real-world health research network, to support data-driven digital solutions to accelerate patient-centric clinical trials, it was reported yesterday.
Lollo Eriksson, Trialbee CEO, said, 'This partnership will significantly widen Trialbee's service offerings to drive patient recruitment and retention. This is a great opportunity to leverage both organisations capabilities to develop new services in order to optimise clinical trials to empower patients with clinical trials as a care option. TriNetX is the market leader in leveraging real world data for the applications of clinical trial design, feasibility and site selection, and we look forward to embarking on this journey together.'
Trialbee says that it develops innovative software to decrease clinical trial recruitment timelines and enhance the patient engagement experience, and TriNetX optimises clinical research and enables discoveries through the generation of real-world evidence. TriNetX's access to patients via its global healthcare organisations partners and through publicly available sources, and Trialbee's expertise in patient recruitment and digital outreach, suggest a multi-pronged approach to identify, engage, and drive patients to clinical trials, improving efficiency and time-to-market.
((Comments on this story may be sent to email@example.com))
|Printer friendly Cite/link Email Feedback|
|Publication:||M2 EquityBites (EQB)|
|Date:||Oct 17, 2019|
|Previous Article:||Brentwood Associates to divest Marshall Retail Group for undisclosed sum.|
|Next Article:||Cal-Maine Foods Inc to acquire egg production assets from Mahard Egg Farm.|